RxDoctor Payments Data

Erika Shepard

Family · Brighton, CONPI 1881132140

Payments from drug & device makers

$421in general payments, 2019–2025

Across 23 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$92
  • Lilly USA, LLC$73
  • Novo Nordisk$50
  • AbbVie$35
  • IBSA Pharma Inc.$33
  • Seqirus USA Inc$22
  • plus $116 from 6 others

What the payments were for

  • Food & beverage$421100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca5$92
Lilly USA, LLC4$73
Novo Nordisk3$50
AbbVie2$35
IBSA Pharma Inc.2$33
Seqirus USA Inc1$22
Ascend Therapeutics US, LLC1$22
Merck1$21
Amgen1$20
GSK1$20
Bayer1$18
Coopersurgical, Inc.1$15

How this compares

$421 in reported general payments places this provider in the 60th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$3,206
Medicare patients
23
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Brighton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →